Pro Palmitoylethanolamide (PEA)

Supports the endocannabinoid system

• Scientifically proven to help reduce chronic pain and inflammation
• A naturally occurring long-chain fatty acid amide commonly produced in response to various triggers, including inflammation
• Provides a multi-pronged approach to activating and maintaining the endocannabinoid system
• Studied for 80 years and by over 300 medical studies

Palmitoylethanolamide (PEA) is a long-chain fatty acid produced naturally by the body but also found in foods such as egg yolk, soybean, and sunflower oils. This molecule, studied for its unique and wide range of health benefits for eighty years, is now receiving special attention due to its crucial role in the endocannabinoid system (ECS). The ECS is a communication network that maintains cellular homeostasis, particularly when tissues are damaged, inflamed, or injured. PEA is an endocannabinoid produced locally by cells, following any injury, physical stress, or pain. By inhibiting the activation of mast cells that cause further inflammation (such as the release of histamine), PEA acts as a potent anti-inflammatory agent. This unique molecule has other direct and indirect mechanisms of action; It enhances the action of other endocannabinoids through its "entourage effect" and its action on many new cellular receptors, including PPAR. The PEA molecule has been clinically shown to have the ability to relieve pain in knee osteoarthritis as well as reduce symptoms of low back pain, and is well tolerated by athletes, children, and the elderly.

AOR Advantage

AOR is leading the way in transforming the impressive and evolving research on the positive effects of EEP in the human endocannabinoid system, bringing your patients a safe and therapeutic formulation to combat chronic pain and systemic inflammation. AOR's PEA is produced in Italy and extracted from environmentally sustainable Malaysian palm oil that is purified and responsibly processed for optimal bioavailability.